Friday, March 21, 2025
spot_img

WithSecure Corporation: SHARE REPURCHASE 20.3.2025

WithSecure Corporation, STOCK EXCHANGE RELEASE, 20 March 2025 at 6.30 PM (EET)  
           
           
WithSecure Corporation: SHARE REPURCHASE 20.3.2025      
           
In the Helsinki Stock Exchange          
           
Trade date           20.3.2025        
Bourse trade         Buy        
Share                  WITH        
Amount             15 000 Shares      
Average price/ share    0,9229 EUR      
Total cost            13 843,50 EUR      
           
           
WithSecure Corporation now holds a total of 211 890 shares      
including the shares repurchased on 20.3.2025        
           
The share buybacks are executed in compliance with Regulation       
No. 596/2014 of the European Parliament and Council (MAR) Article 5    
and the Commission Delegated Regulation (EU) 2016/1052.      
           
           
On behalf of Withsecure Corporation        
           
Nordea Bank Oyj          
           
Janne Sarvikivi           Sami Huttunen        
           
           
Contact information:          
Laura Viita          
Vice President Controlling, Investor relations and Sustainability    
WithSecure Corporation          
Tel. +358 50 4871044          
[email protected]          
           

Attachment

  • WithSecure 20.3.2025

Powered by SlickText.com

Hot this week

CPS Announces $65.0 Million Securitization of Residual Interests

LAS VEGAS, Nevada, March 20, 2025 (GLOBE...

Xcel Energy to Deploy Advanced Virtual Power Plant in Colorado with Itron and Tesla

Integration of Itron's IntelliFLEX Aggregator DERMS Solution and Tesla...

ATN Board Declares Quarterly Dividend

BEVERLY, Mass., March 20, 2025 (GLOBE NEWSWIRE)...

Topics

Xcel Energy to Deploy Advanced Virtual Power Plant in Colorado with Itron and Tesla

Integration of Itron's IntelliFLEX Aggregator DERMS Solution and Tesla...

ATN Board Declares Quarterly Dividend

BEVERLY, Mass., March 20, 2025 (GLOBE NEWSWIRE)...

Credit Acceptance Named 2025 Top Workplaces USA Award Winner

Southfield, Michigan, March 20, 2025 (GLOBE NEWSWIRE)...

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results

Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study...

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor,...
spot_img

Related Articles

Popular Categories

spot_img